Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experience.

Autor: Seitter SJ; Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., McClelland PH; Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Ahlman MA; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Goff SL; Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Yang JC; Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., McIntyre L; Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Rosenberg SA; Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kochenderfer JN; Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Brudno JN; Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Jazyk: angličtina
Zdroj: Leukemia & lymphoma [Leuk Lymphoma] 2022 Oct; Vol. 63 (10), pp. 2469-2473. Date of Electronic Publication: 2022 Jun 09.
DOI: 10.1080/10428194.2022.2076853
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje